APOE and Alzheimer disease: In addition, as mentioned above, the seeding activity (maximum ThT fluorescence) is higher in patients with AD and concomitant LBD who are APOE ε4 carriers, as compared with APOE ε4 non-carries (Jin et al., 2022).